Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Biotron's BIT-225 completes proof-of-concept trial in HIV

Dec. 17, 2012

Regulatory approvals received for new study of Vacc-4x

Dec. 7, 2012

Japan Tobacco applies for approval of single-tablet anti-HIV regimen in Japan

Dec. 7, 2012

Phase I study confirms safety and immunogenicity of HIV vaccine

Dec. 5, 2012

Altravax receives grant from NIH to develop vaccines for HIV/AIDS

Dec. 4, 2012

Theravectys receives clearance for first human trial of anti-HIV vaccine

Dec. 4, 2012

European Commission approves Viread for two new indications

Nov. 28, 2012

Gilead Sciences discloses novel agents for AIDS

Nov. 23, 2012

Chinese researchers present new agents for HIV

Nov. 16, 2012

Novel agents for HIV infection synthesized by Bristol-Myers Squibb

Nov. 15, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...